FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big TechForbes • 07/29/26
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 07/28/26
Hims & Hers: Peptide Ruling A Positive, Operational Good Sense Makes 'Buy' Case (Upgrade)Seeking Alpha • 07/24/26
QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'Benzinga • 07/23/26
Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds HigherInvestors Business Daily • 07/23/26
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the CompanyBusiness Wire • 07/17/26
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 07/14/26
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026Business Wire • 07/13/26
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?Zacks Investment Research • 07/13/26
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader MarketZacks Investment Research • 07/07/26
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 07/07/26
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 06/29/26